Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactImpact of hepatitis C virus infection on bone mineral density in renal transplant recipientsPilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.Renal transplantation in systemic lupus erythematosus: outcome and prognostic factors in 50 cases from a single centre.Renal transplantation in patients with hepatitis C virus antibody. A long national experience.Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Treatment of chronic hepatitis C virus infection in dialysis patients: an updateManagement of hepatitis C in patients with chronic kidney disease.Management of the kidney transplant patient with chronic hepatitis C infectionEqual 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With CirrhosisEffect of kidney transplantation on outcomes among patients with hepatitis CHepatitis C and kidney transplantationKidney transplantation from donors with hepatitis C infection.The influence of induction therapy for kidney transplantation after a non-renal transplant.Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East IranPost-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies.Review article: hepatitis C virus and calcineurin inhibition after renal transplantation.Impact of donor and recipient hepatitis C status in lung transplantationIncreased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort studyNeed for quality improvement in renal systematic reviews.The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipientsPrevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran.Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.Chronic viral hepatitis in kidney transplantation.Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future.Dilemma of HCV infection in renal transplant recipients.Hepatitis C and renal transplantation.Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.Meta-analysis of observational studies: hepatitis C and survival after renal transplant.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Hepatitis C and its impact on renal transplantation.Hepatitis C infection and chronic renal diseases.HCV and the kidney.Ledipasvir and sofosbuvir for treatment of post- renal transplant hepatitis C infection: A case report with review of literatureEpidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil.Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.Elderly living donor kidney transplantation allows worthwhile outcomes: The Japan Academic Consortium of Kidney Transplantation study.Renal transplantation in hepatitis C positive patients: a single centre experience.
P2860
Q22299128-DC28AFD2-22AE-4ACF-BEFA-0906169E0251Q28487941-1FEE7E0F-243B-40FF-A01B-02B445E52A9FQ33374217-288ED535-2225-40A4-8B29-501583445567Q33810462-A3E56A51-4009-4D82-B19E-B1CEB6C81BEEQ33871282-2A0696E5-8950-4031-AD12-E60F4609C847Q33969758-05FAF59B-283D-48CE-B1AD-BE53BEB26D8DQ34340554-6806DED6-C4FC-47B7-8270-C394C6622A83Q34932338-27DCCF4D-A2B0-463A-B67E-37F40F1EA508Q34988932-3512B38B-1B70-40FC-BB16-5D4AAC01049DQ34993200-DD4C7955-AE90-4EE8-A458-19A92AC06580Q35012447-96B9798F-7C3C-4F0A-A591-983A32E7AA5DQ35094769-136DACE0-D179-4E17-8A48-31897F08B190Q35128555-DF90D625-E73F-4C76-83E7-8F13F247F4C0Q35692427-5E8EC5FC-C86E-49B3-AEB1-C45F13432BE5Q36075061-25688E08-330F-4558-BCB5-0E9A02AAF7C1Q36257275-9186BB73-B3DD-442A-BC97-426176CC8049Q36273519-1B38A76E-EF5B-49B7-84CB-F9DEB3C3977BQ36563693-55E5E412-8BF0-4CC2-87DA-2BB83909FE8DQ36595414-77F9A871-F2CD-4699-9E1B-BCF3FFD8BC1DQ36736617-91C1D8F4-9ACF-4441-8889-88CA3D73B9ABQ37361121-B67F4C11-A557-4341-9DFD-005EA1846F8AQ37420014-F200A763-B545-4A47-92BA-B9E75A420662Q37632074-0601416C-0828-4423-8C1F-D2A6D84F89E4Q37692546-64B76F7D-0ED9-4E6B-B7B2-A7D316753D95Q37697588-AB946EB9-1A0D-4D84-BF3B-6BB3E2D23593Q37833898-D16FB4B8-3D99-485A-B661-1B4FC67CADA2Q37846232-5DFE8B82-B4C5-41B7-8049-6BA40F3D492CQ37887523-1A2A34C3-4602-403B-AB67-167EAFD0B62BQ38017157-545AD29E-C9E3-4C39-8178-910B8C5E221DQ38194499-ED33326D-2749-4EB5-8172-4C83C3AF60E9Q38203314-F3EF7F53-3538-4495-B1A2-3FE473531FC7Q38213956-AAFDBE11-A5EB-4D8D-9F60-3F0B6A80EE43Q38341218-C937C761-2D82-4481-9D94-372321AE9FBAQ38552198-AEA22227-0306-48DB-873C-9C426A5AA9C0Q38685571-8A4A95C6-DA1F-46B9-94F2-36A08A0C920CQ38838138-182D2216-4791-4A19-BDDF-BC0C69858E27Q38915912-2F53C7D8-CAC4-4F13-AA13-8A8344DB7750Q39138199-EC7E827B-C4B5-4307-82BA-9179445AEFC7Q40039348-AEB529ED-5D0B-48A4-BAE6-153272F74F97Q40136234-7CD5A5F9-9F2B-441B-8809-7547FB5BCDC5
P2860
Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatitis C virus antibody sta ...... ysis of observational studies.
@ast
Hepatitis C virus antibody sta ...... ysis of observational studies.
@en
type
label
Hepatitis C virus antibody sta ...... ysis of observational studies.
@ast
Hepatitis C virus antibody sta ...... ysis of observational studies.
@en
prefLabel
Hepatitis C virus antibody sta ...... ysis of observational studies.
@ast
Hepatitis C virus antibody sta ...... ysis of observational studies.
@en
P2093
P2860
P1476
Hepatitis C virus antibody sta ...... ysis of observational studies.
@en
P2093
Fabrizio Fabrizi
Gareth Dulai
Paul Martin
Suphamai Bunnapradist
Vivek Dixit
P2860
P304
P356
10.1111/J.1600-6143.2005.00864.X
P407
P577
2005-06-01T00:00:00Z